EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc ., a global CRO, and Medicover Integrated Clinical ...

Unemployment remains one of the most pressing issues in Africa, impacting economic growth and social stability .

In today's demanding world, maintaining optimal health and well-being is more important than ever. Many men seek natur ...

Former deputy president Rigathi Gachagua and Wiper party leader Kalonzo Musyoka are said to be in talks to plot against ...

In the realm of male enhancement products, the quest for a solution that delivers on its promises can feel daunting. With ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers and payers in the U.S.UK ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

For decades, GZUCM has been committed to bringing Chinese medicine as the valuable heritage to the world through international cooperation in education, research, and healthcare ... actively ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript November 4, 2024 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank ...